Runyao Zhu

This paper develops engineered dendritic cell-derived small extracellular vesicles that combine T-cell priming with checkpoint reprogramming to enhance antitumor immunity.

This study investigates how chiral ligand modulated graphene quantum dots (GQDs) form distinct nanostructures that influence passive and active enantioselective transport across biological membranes.

This study demonstrates that M1 macrophage-derived small extracellular vesicles (sEVs) act as dual-action nanotherapeutics by combining innate immune-regulatory functions with drug delivery, achieving synergistic anticancer effects.

This paper develops a nanochirality-programmed photosensitizer for deep-tumor PDT by enhancing ROS production and reducing matrix adhesion.

This study develops N-Amino Peptide-Graphene Quantum Dot loaded small extracellular vesicles to target tauopathies, showing improved specificity and efficacy in inhibiting tau aggregation and transmission.

This study uses chiral quantum dots to investigate origin-dependent exosome uptake and cargo release mechanisms in different recipient cells.

This study shows that left-handed graphene quantum dots (L-GQDs) have higher diffusion and drug delivery efficacy in tumor-like spheroids compared to right-handed D-GQDs.